Related Experiment Video
Updated: Aug 10, 2026

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
Risk factor variability and coronary heart disease
1Institute of Medical Genetics, University of Oslo, Norway.
Insights
This study identifies specific genes influencing coronary heart disease (CHD) risk factors. Researchers found gene variations affecting cholesterol and body mass index, highlighting genetic contributions to cardiovascular health.
Area of Science:
- Genetics and Molecular Biology
- Cardiovascular Disease Research
- Human Genetics
Background:
- Coronary heart disease (CHD) risk is influenced by genetic factors, with current research focusing on candidate genes.
- Genes can act as 'level genes' affecting absolute risk factor levels or 'variability genes' influencing environmental interactions.
- Understanding these genetic roles is crucial for identifying CHD risk.
Purpose of the Study:
- To identify specific genes contributing to coronary heart disease (CHD) risk factors.
- To differentiate between 'level genes' and 'variability genes' in the context of CHD.
- To investigate gene-gene interactions in determining cardiovascular risk factors.
Main Methods:
- Analysis of DNA polymorphisms in genes related to lipid metabolism and CHD risk factors.
- Utilizing the Norwegian Twin Panel for genetic association studies.
- Investigating gene-gene interactions using restriction fragment length polymorphisms (RFLPs).
Main Results:
- Confirmed 'level gene' effects for apolipoprotein B (apoB) concentration via apoB locus polymorphism.
- Identified 'variability gene' effects for apoB and body mass index in the 3' region of the apoB gene.
- Detected 'level' and 'variability' gene effects for cholesterol levels with CETP locus polymorphisms.
- Discovered gene-gene interaction between apoE and LDLR polymorphisms affecting cholesterol levels.
- Established linkage between high Lp(a) lipoprotein levels and plasminogen locus RFLPs, identifying LPA locus variation.
Conclusions:
- Specific gene polymorphisms in apoB, CETP, apoE, LDLR, and LPA loci significantly influence CHD risk factors.
- Gene-gene interactions play a role in modulating cardiovascular risk.
- Genetic variations provide insights into the complex etiology of coronary heart disease.
Abstract:
Present attempts to identify genes contributing to coronary heart disease (CHD) risk focus on "candidate genes". With respect to CHD this could be any gene whose protein product is directly or indirectly involved in atherogenesis, thrombogenesis or thrombolysis/fibrinolysis. Genes that exhibit associations with absolute risk factor levels may be referred to as "level genes" to distinguish them from "variability genes", which are genes involved in establishing the framework within which environmental influences may cause risk factor variation. In a series of persons recruited from the Norwegian Twin Panel, confirmatory evidence for level gene effect with respect to apolipoprotein B (apoB) concentration was found with an XbaI polymorphism in DNA at the apoB locus corresponding to residue 2,488 in the mature protein. Evidence for variability gene effect with respect to apoB as well as body mass index emerged with DNA variants in the 3' part of the apoB gene. Level gene effect with respect to apolipoprotein A-I (apoA-I) and high density lipoprotein (HDL) cholesterol as well apparent variability gene effect with respect to total and LDL cholesterol were detected with a DNA polymorphism at the cholesteryl ester transfer protein (CETP) locus. The first example of interaction between normal genes in determining risk factor level was uncovered in analysis of the apolipoprotein E (apoE) polymorphism and a restriction fragment length polymorphism (RFLP) at the low density lipoprotein receptor (LDLR) locus. An LDLR gene identified by presence of a PvuII restriction site eliminated completely the well known effect of the apoE4 allele on cholesterol level. Finally, in families where high Lp(a) lipoprotein level (a well established risk factor for CHD) segregated as a Mendelian trait, very close linkage with an RFLP at the plasminogen locus was established and DNA variation at the LPA locus reflecting varying numbers of a structure homologous to the "kringle IV" region of plasminogen was uncovered.
Related Concept Videos
Factors Influencing Heart Rate
Let us explore the significant factors affecting heart rate, including age, body temperature, posture, acute pain, chemical influences,...
Variability: Analysis
The range is a simple measure of variability, indicating the difference between the highest and...
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease IV: Preventive Measures
